Company Quick10K Filing
Punto Group
10-Q 2019-09-30 Filed 2019-11-14
S-1 2019-09-12 Public Filing
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-29
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-04
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-26
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-17
10-K 2015-12-31 Filed 2016-04-14
10-K 2015-09-30 Filed 2015-10-22
10-Q 2015-06-30 Filed 2015-08-17
8-K 2020-05-15 Other Events
8-K 2020-05-04 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2020-03-30 Other Events
8-K 2020-02-12 Officers, Amend Bylaw, Shareholder Vote, Other Events, Exhibits
8-K 2019-12-06 Enter Agreement, Other Events, Exhibits
8-K 2019-02-21 Enter Agreement, M&A, Off-BS Arrangement, Sale of Shares, Accountant, Control, Officers, Shell Status, Exhibits
8-K 2019-01-07 Shareholder Rights, Amend Bylaw, Exhibits
8-K 2018-11-30

Punto Group Financials

PNTTE Metrics, Comps, Filings

Quarterly | Annual

Business

We plan to be the worldwide industry leader in the production and manufacturing of raw cannabis and hemp plant ingredients for both medical and industrial uses. We have received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, we are one of the first companies in Colombia to receive licenses for seed, cultivation, extraction and export from the Colombian government (the “Licenses”).

Our primary cultivation site is located in Popayan, Colombia. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp, with 221 acres available for expansion under an exclusive contract. We use innovative, proprietary cannabis micropropagation techniques to cultivate stable, robust, genetically superior cannabis and hemp derived products. We produce under GAP/GMP/EU Pharmacopoeia standards and intend for our products to be available and accessible to all large-scale purchasers at market competitive price points. Due to our proximity to the equator, we are able to grow year-round.

The plants are first processed into crude cannabis oil using ethanol. We further process the crude cannabis oil into distillate using a film wipe distillation machine which removes unwanted contaminates. We can further process the distillate into isolate resulting in a pure isolate powder with 99% purity. We are able to sell off the product at the end of any of these processes. Our primary products are crude cannabis, distillate and isolate.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Stemcell Holdings (STMM) 113% -1.0 26% 12,033 6,023 7,314 8,235 3,099 4,927 -5,116
FCCC (FCCC) 1.5 -61% 92 3 0 0 -56 -56 -82
Tapinator (TAPM) 0% 0.1 -99% 1,783 952 4,323 0 -1,762 -1,762 -260
Nogales Resources (NLRT) 0% 1 188 0 0 0 0 -1
Golden Growers Cooperative (GGRO) -0% 0% 26,919 2,171 42,425 -45 0 0 -3,508
Northern Power Systems (NPS) 22% 0.4 -27% 8,927 13,901 18,317 4,050 -2,379 -1,701 -670
Twin River Worldwide (TRWH) 0% 4.0 4% 1,070,918 808,153 393,158 0 41,775 112,100 449,560
Bio-En (BENH) 0.1 -643% 10 149 0 0 -67 -67 -5
Southwest Iowa Renewable Energy (SIRE) -1% -47.3 -1% 140,863 51,558 216,993 -1,931 -1,170 -537 25,396
Texas Republic Capital (TRCC) 0% 8.9 -5% 26,315 14,988 931 0 -1,274 -1,274 -11,328
Fannie Mae (FNM) 28.1 0% 3,494,436,000 3,484,094,000 0 0 13,025,000 119,732,000 3,361,548,000
CBA Florida (CBAI) 43.6 -1% 14,544 598 0 0 -211 -261 -11,368
Pacific Gold & Royalty (PCFG) -7.1 0 3,799 0 -3 -238 -45 320
BoxScore Brands (BOXS) 33% -8.3 -540% 313 7,564 338 110 -1,690 -702 5,793
Quest Management (QUEST) 27% -0.3 129% 13 6 45 12 16 16 -5
Zhen Ding Resources (RBTK) 0.1 48,309,900% 0 0 -483 -68 -6
Hines Global REIT (HGRI) 0% 1.7 19% 2,010,946 999,520 205,149 0 388,366 421,651 715,767
Wadena (WDN) 0% 0.0 -2,344% 12 696 87 0 -281 -278 -5
Galera Therapeutics (GRTX) 1.3 -17% 79,758 52,298 0 0 -13,351 -12,433 -15,719
Chase General (CSGN) 26% -0.5 -2% 1,563 1,016 2,493 658 -32 13 -7

Balance Sheet ($'000)2015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash18630000000000001,462212956
Accounts Receivable
Inventory92522
PP&E432721579
Assets196300000000012,3671,4162,116
Accounts Payable0146175144
Long-Term Debt300300507
Liabilities3323132332415361689810511212401,5151,342951
Stockholders' Equity3-20-1323-32-41-53-61-68-98-105-112-1240852741,165
Income Statement ($'000)2015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000000000000000
Cost of Revenue
Gross Profit
R&D
SG&A212228109101187317712480565589
Tax0000000000
Net Income-2-20-226-10-9-10-11-8-7-31-7-7-12-1,324-1,325-1,797
Cash Flow ($'000)2015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-20-141164-30-3-16-11-27-1-12-13-982-951-1,182
Cash Investing-73-293142
Cash Financing811-14-7-4303161127112132,401-1571,947